Immutep LTD ADR buy Mori8
Start price
20.09.16
/
50%
€2.62
Target price
27.09.16
€3.60
Performance (%)
0.00%
End price
27.09.16
€2.62
Summary
This prediction ended on 27.09.16 with a price of €2.62. The BUY prediction by Mori8 closed unchanged from the start price. Mori8 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Immutep LTD ADR | 0.901% | 0.901% | 18.519% | 28.736% |
| iShares Core DAX® | 0.463% | -1.999% | 9.981% | 58.545% |
| iShares Nasdaq 100 | -1.792% | -5.743% | -0.781% | 80.511% |
| iShares Nikkei 225® | 5.124% | 9.091% | 28.823% | 62.776% |
| iShares S&P 500 | -1.760% | -3.669% | -0.543% | 54.389% |
Comments by Mori8 for this prediction
In the thread Immutep LTD ADR diskutieren
Das Unternehmen konzentriert sich auf die Immuntherapie von Krebs-Forschung.
Brokers have set a twelve-month consensus target price of $5.00 for the company, according to Zacks.